Zobrazeno 1 - 10
of 662
pro vyhledávání: '"Lars Eckardt"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Patients with an implantable cardioverter-defibrillator (ICD) often report psychological distress. Literature suggests that patients with physical disease often compare their well-being and coping to fellow patients. However, we lack knowled
Externí odkaz:
https://doaj.org/article/fbc482b49034480d92d2c6be41bd1135
Autor:
Sati Güler, Hilke Könemann, Julian Wolfes, Fatih Güner, Christian Ellermann, Benjamin Rath, Gerrit Frommeyer, Philipp Sebastian Lange, Julia Köbe, Florian Reinke, Lars Eckardt
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 12, Pp 2429-2437 (2023)
Abstract Lidocaine is classified as a class Ib anti‐arrhythmic that blocks voltage‐ and pH‐dependent sodium channels. It exhibits well investigated anti‐arrhythmic effects and has been the anti‐arrhythmic of choice for the treatment of vent
Externí odkaz:
https://doaj.org/article/265c3cbf7c2044ab8466db63e6a08ad8
Autor:
Julian Wolfes, Jan Uphoff, Sven Kemena, Felix Wegner, Benjamin Rath, Lars Eckardt, Gerrit Frommeyer, Christian Ellermann
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundThe use of SGLT-2 inhibitors has revolutionized heart failure therapy. Evidence suggests a reduced incidence of ventricular and atrial arrhythmias in patients with dapagliflozin or empagliflozin treatment. It is unclear to what extent the r
Externí odkaz:
https://doaj.org/article/8b44ee1c72754d0b872c3e7e58d10b2e
Autor:
Elke Boxhammer, Meriem Bellamine, Istvan Szendey, Mike Foresti, Marc Bonsels, Joseph Kletzer, Peter Jirak, Albert Topf, Johannes Kraus, Lukas Fiedler, Anna-Maria Dieplinger, Uta C. Hoppe, Bernhard Strohmer, Lars Eckardt, Rudin Pistulli, Lukas J. Motloch, Robert Larbig
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionWhile in the CASTLE-AF trial, in patients with atrial fibrillation and heart failure with reduced ejection fraction, interventional therapy using pulmonary vein isolation was associated with outcome improvement, data on cavotricuspid isth
Externí odkaz:
https://doaj.org/article/e7c1f4a8bec74a46864e783660c1dc2f
Autor:
Felix K. Wegner, Robert Radke, Christian Ellermann, Julian Wolfes, Alicia J. Fischer, Helmut Baumgartner, Lars Eckardt, Gerhard-Paul Diller, Stefan Orwat
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract Guidelines recommend transesophageal echocardiography (TEE) before cardioversion in thrombogenic arrhythmias when the requirement of ≥ 3 weeks of anticoagulation is not met. Current data to support this approach, especially with direct ora
Externí odkaz:
https://doaj.org/article/3d3bad214e9d46b29e0540dbbf2e082d
Autor:
Nils Bögeholz, Vincent Knappe, Paul Pauls, Jan S. Schulte, Joshua I. Goldhaber, Frank U. Müller, Georg Nickenig, Lars Eckardt, Jan W. Schrickel, Thomas Beiert
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 44, Iss , Pp 101168- (2023)
Aims: Na+/Ca2+ exchanger (NCX) upregulation in cardiac diseases like heart failure promotes as an independent proarrhythmic factor early and delayed afterdepolarizations (EADs/DADs) on the single cell level. Consequently, NCX inhibition protects agai
Externí odkaz:
https://doaj.org/article/0c3b1083b3bb430fa0b58ed94c2d0e29
Autor:
Christian Ellermann, Jonas Brandt, Julian Wolfes, Kevin Willy, Felix K. Wegner, Patrick Leitz, Philipp S. Lange, Florian Reinke, Lars Eckardt, Gerrit Frommeyer
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Previous studies suggest an impact of dexmedetomidine on cardiac electrophysiology. However, experimental data is sparse. Therefore, purpose of this study was to investigate the influence of dexmedetomidine on different experimental models o
Externí odkaz:
https://doaj.org/article/54866093fa3242f98f50a76417f57ea0
Autor:
Pier D. Lambiase, MBChB, PhD, FHRS, Lars Eckardt, MD, Dominic A. Theuns, PhD, Timothy R. Betts, MD, Andreas L. Kyriacou, MBChB, FRCP, PhD, CCDS, Elizabeth Duffy, MS, Reinoud Knops, MD, PhD, CCDS
Publikováno v:
Heart Rhythm O2, Vol 1, Iss 5, Pp 326-335 (2020)
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is an alternative to conventional transvenous ICD (TV-ICD) therapy to reduce lead complications. Objective: To evaluate outcomes in channelopathy vs patients with structural
Externí odkaz:
https://doaj.org/article/a9c8ef274f614046b43c94999f3c908f
Autor:
Elif Kaya, Jochen Senges, Matthias Hochadel, Lars Eckardt, Dietrich Andresen, Hüseyin Ince, Stefan G. Spitzer, Thomas Kleemann, Sebastian S.K. Maier, Werner Jung, Christoph Stellbrink, Tienush Rassaf, Reza Wakili
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 984-995 (2020)
Abstract Aims Diabetes mellitus (DM) has a negative impact on prognosis in patients with heart failure (HF). The role impact of DM in HF patients with implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) devices mig
Externí odkaz:
https://doaj.org/article/838d61bc77334bbaa866f4160c7a0a7d
Autor:
Viktoria Holtstiege, Claudia Meier, Michael Bietenbeck, Grigorios Chatzantonis, Anca Florian, Julia Köbe, Florian Reinke, Lars Eckardt, Ali Yilmaz
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 22, Iss 1, Pp 1-12 (2020)
Abstract Background Cardiovascular magnetic resonance (CMR) studies in patients with implanted cardioverter/defibrillators (ICD) are increasingly required in daily clinical practice. However, the clinical experience regarding the feasibility as well
Externí odkaz:
https://doaj.org/article/79dfe238240f4d219973ff1971e1ac40